Verapamil
Verapamil is an orally active, non-dihydropyridine calcium channel blocker that also inhibits P-glycoprotein and CYP3A4. It is widely used in research on hypertension, angina, and cardiac conditions, serving as a key pharmacological tool for in vitro and in vivo studies of calcium signaling and drug transport.
Product Specifications
CAS Number
52-53-9
Product Name Alternative
CP-16533-1, CYP3A4, CYPs, Cytochrome P450, Cluster of differentiation 243, CalciumChannel, CD243, ABCB1, (±) -Verapamil, angina, antiarrhythmic, Ca channels, Ca2+ channels, Calcium Channel, blood, inhibit, Multidrug resistance protein 1, NSC 135784, Palbociclib, lysosomotropic, NSC135784, NSC-135784, Inhibitor, high, MDR1, pressure, Pgp, P-gp, P-glycoprotein, Verapamil
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
99.53% (May vary between batches)
Solubility
DMSO:45 mg/mL (98.99 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4.5 mg/mL (9.9 mM)
Smiles
COc1ccc (CCN (C) CCCC (C#N) (C (C) C) c2ccc (OC) c (OC) c2) cc1OC
Molecular Formula
C27H38N2O4
Molecular Weight
454.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
FHE85421 100 Tests
Anti-Human Sulfated CD195/CCR5 Antibody (RoAb13), FITC
Sign In for Pricing
View Details 